WASHINGTON, D.C., January 13, 2004 - The Council for Responsible Nutrition (CRN), one of the dietary supplement industry's leading trade associations, has announced the addition of the following companies to its membership roster: Amerilab Technologies of New Hope, Minn.; PROSAR of St. Paul, Minn.; Shionogi Qualicaps of Whitsett, N.C.; and Unigen Pharmaceuticals of Broomfield, Colo. Amerilab, Shionogi Qualicaps and Unigen join as voting members, while PROSAR will be an associate member.
"As we face the challenges of the new year, it is rewarding to know that CRN continues to garner the interest of responsible companies that have a desire to raise the bar and set higher standards for the entire industry," said Annette Dickinson, Ph.D., president, CRN. "We look forward to working closely with these four companies."
Amerilab Technologies is a developer, manufacturer and packager of effervescent tablets and powders. Their products encompass nutritional and herbal supplements, as well as OTC and pharmaceutical products.
PROSAR is a medical call center staffed 24/7 to manage product-related adverse incidents and other health-related inquiries. PROSAR utilizes leading edge technology to help client companies meet the requirements for regulatory compliance, risk management and consumer expectations regarding corporate responsibility.
With manufacturing sites in the United States, Europe and Japan, Shionogi Qualicaps is a manufacturer of two-piece empty gelatin and hypromellose capsules. They also design fully automatic, high-speed, capsule-filling and capsule-sealing machines. Shionogi has a long-term commitment to the research and development of new capsule technologies and applications.
Unigen Pharmaceuticals is a research and development company specializing in licensing unique, patented and proprietary compounds for use in cosmeceutical, nutraceutical and pharmaceutical products, as well as dietary supplements. Unigen and its sister R&D facility in South Korea have developed numerous proprietary products and licensed them to healthcare companies throughout the world.